跳至主要内容
临床试验/JPRN-UMIN000007629
JPRN-UMIN000007629招募中未知

Pharmacokinetic analysis of docetaxel and dexamethasone in combination with aprepitant in Japanese patients with solid tumors. - Pharmacokinetic analysis of docetaxel and dexamethasone in combination with aprepitant.

Saitama Medical University, International Medical Center0 个研究点目标入组 30 人开始时间: 2012年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with contraindication to docetaxel, involved with bone marrow suppression, active infection, severe hypersensitivity to ingredients contained by docetaxel. 2. Patients with contraindication to aprepitant. 3. Patient with pleural effusion or ascites which should be drainaged. 4. Patients have received chemotherapy including any drug except docetaxel, or radiation therapy within 3 weeks prior to registration. 5. Patients have hormonal therapy within 7 days prior to registration. 6. Women of childbearing potential and men of impregnating potential who don't agree to use adequate contraception, pregnant women, and lactating women. 7. History of severe hypersensitivity to a medicine. 8. Patients with the habit of smoking within one month prior to registration. 9. Patients with any conditions that are unstable or jeopardize the safety of the patient and his/her compliance in the study.

研究者

相似试验